Indivior (INDV)

Sector:

Pharma and Biotech

Index:

FTSE 250

 845.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 1,445.00
  • 52 Week Low: 576.50
  • Currency: UK Pounds
  • Shares Issued: 40.29m
  • Volume: 0
  • Market Cap: £340.68m
  • RiskGrade: 314

Indivior Overview

Indivior is a pharmaceutical company specialising in addiction treatment. Indivior was spun out of parent Reckitt Benckiser in December 2014. Adding to its Suboxone opioid addiction product, the company has a pipeline including longer-lasting 'depot' formulations, treatments for cocaine intoxication, alcohol addiction and even schizophrenia, as a psychiatric co-morbidity of addiction.

Key Personnel

CEO: Mark Crossley
Chairman: David E. Wheadon
Independent Non-Executive Director: Jo Le Couilliard
Independent Non-Executive Director: Mark Stejbach
Independent Non-Executive Director: Peter Bains
Independent Non-Executive Director: Joe Ciaffoni
Independent Non-Executive Director: Barbara Ryan
Independent Non-Executive Director: Daniel A. Ninivaggi
Independent Non-Executive Director: Keith Humphreys
Senior Independent Director: Juliet Thompson
Non-Executive Dir:

Contact Details

Address: 234 Bath Road, Slough, Berkshire, United Kingdom, SL1 4EE
Website: http://www.Indivior.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE 250, FTSE 350, FTSE All-Share
Overseas Listings: BATSLON:INDVL
ISIN: GB00BN4HT335

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Indivior Market Data

Currency UK Pounds
Share Price 845.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 1,445.00
52 Week Low 576.50
Volume 0
Shares Issued 40.29m
Market Cap £340.68m
RiskGrade 314

Indivior Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
54.74% below the market average54.74% below the market average54.74% below the market average54.74% below the market average54.74% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Price Trend
67.60% above the market average67.60% above the market average67.60% above the market average67.60% above the market average67.60% above the market average
2.13% above the sector average2.13% above the sector average2.13% above the sector average2.13% above the sector average2.13% above the sector average
Income Not Available
Growth
50.98% above the market average50.98% above the market average50.98% above the market average50.98% above the market average50.98% above the market average
18.75% above the sector average18.75% above the sector average18.75% above the sector average18.75% above the sector average18.75% above the sector average

What The Brokers Say

Strong Buy 2
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 4
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Indivior Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

Indivior Key Personnel

CEO Mark Crossley
Chair David E. Wheadon

Top of Page